We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Three-Dimensional Growth Chamber Promotes Understanding of Angiogenesis

By LabMedica International staff writers
Posted on 11 Feb 2019
Collaboration between French and Japanese researchers resulted in the development of a three-dimensional "microvessel-on-a-chip" device for advancing the understanding of the processes that drive angiogenesis (production of new blood vessels).

Elucidating the mechanisms underlying sprouting angiogenesis and permeability should enable the development of more effective therapies for various diseases, including retinopathy, cancer, and other vascular disorders. More...
Sprouting angiogenesis was the first identified form of angiogenesis. It occurs in several well-characterized stages. First, biological signals known as angiogenic growth factors activate receptors on endothelial cells present in pre-existing blood vessels. Second, the activated endothelial cells begin to release proteases that degrade the basement membrane to allow endothelial cells to escape from the original (parent) vessel walls.

The endothelial cells then proliferate into the surrounding matrix and form solid sprouts connecting neighboring vessels. As sprouts extend toward the source of the angiogenic stimulus, endothelial cells migrate in tandem, using adhesion molecules called integrins. These sprouts then form loops to become a full-fledged vessel lumen as cells migrate to the site of angiogenesis. Sprouting occurs at a rate of several millimeters per day, and enables new vessels to grow across gaps in the vasculature.

Investigators at the Institute of Industrial Science of the University of Tokyo (Japan) and the French National Center for Scientific Research (Lille, France) focused on the protein EGFL7 (epidermal growth factor-like domain 7), which plays an important role in NOTCH signaling and in the organization of angiogenic sprouts. For this purpose they developed a three-dimensional EGFL7-knockdown in vitro microvessel model in order to investigate the effect of EGFL7 at a tissue level.

The investigators reported in the March 2019 online edition of the journal Biomaterials that EGFL7 knockdown suppressed vascular endothelial growth factor A (VEGF-A)-induced sprouting angiogenesis accompanied by an overproduction of endothelial filopodia and reduced collagen IV deposition at the basal side of endothelial cells. They also observed impaired barrier function, which reflected an inflammatory condition. Furthermore, the results showed that proper formation of adherens junctions and phosphorylation of VE-cadherin was disturbed.

"We obtained more insight into how blood vessels form by building our own in the lab from scratch, first forming a collagen mold containing a needle that was then removed, leaving a space that was then colonized by human umbilical vein endothelial cells," said senior author Dr. Yukiko T. Matsunaga, associate professor of biomedical engineering at the University of Tokyo. "We next examined the effects of EGFL7 by comparing two models of this type, one in which this molecule was allowed to function normally in these cells and another in which it was knocked down by siRNA."

Related Links:
Institute of Industrial Science of the University of Tokyo
French National Center for Scientific Research


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.